Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibandronate in postmenopausal osteoporosis with and without type 2 diabetes
NCT05266261Completed
- Sponsor
- The Catholic University of Korea Yeouido St. Mary's Hospital
- Start
- Oct 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ibandronate in postmenopausal osteoporosis, sponsored by The Catholic University of Korea Yeouido St. Mary's Hospital. Primary endpoint: Bone Mineral Density at 1 year. Started Oct 2018; status: completed.
02
Drugs
ibandronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT05266261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05266261.